Pasithea Therapeutics Corp.

Nasdaq:KTTANasdaq:KTTAW

Pharmaceutical Preparations·MIAMI BEACH, FL

In Greek mythology, Pasithea, Pasithee or Pasitheia, was one of the Graces and the wife of Hypnos. In the Dionysiaca, the epic poem of Nonnus, she is one of the three attendant Graces of Aphrodite.

CEO

Marques Tiago

CFO

Schneiderman Daniel H

Financials

19 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-Q	Q1 2025	3/31/25	5/15/25	→
10-K	FY 2024	12/31/24	3/24/25	→
10-Q	Q3 2024	9/30/24	11/13/24	→
10-Q	Q2 2024	6/30/24	8/13/24	→
↓

News (8-K)

40 shown

Filed	Type	Description
2/20/26	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
1/28/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/15/25	Other	Other Events	→
12/2/25	Agreement	Entry into a Material Definitive Agreement	→
11/25/25	Reg FD	Regulation FD Disclosure	→
11/4/25	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
1/30/26	S-8	REGISTRATION STATEMENT	→
12/1/25	424B4	424B4	→
11/26/25	S-1/A	AMENDMENT NO. 1 TO FORM S-1	→
11/18/25	S-1	REGISTRATION STATEMENT	→
9/9/25	S-8	REGISTRATION STATEMENT	→
7/24/25	ARS	ARS	→
↓

Filing History(303 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G

Feb 27, 2026

0001104659-26-021537

—

26.4 KB

8-K

Feb 20, 2026

0001213900-26-018874CURRENT REPORT

Feb 20, 2026

235.7 KB

SCHEDULE 13G/A

Feb 17, 2026

0001649553-26-000028

—

11.5 KB

SCHEDULE 13G/A

Feb 17, 2026

0002050709-26-000003

—

79.5 KB

SCHEDULE 13G

Feb 17, 2026

0001193125-26-053451

—

96.0 KB

SCHEDULE 13G

Feb 12, 2026

0000902664-26-000884

—

16.1 KB

S-8

Jan 30, 2026

0001213900-26-010202REGISTRATION STATEMENT

—

202.0 KB

8-K

Jan 28, 2026

0001213900-26-008828CURRENT REPORT

Jan 28, 2026

268.4 KB

EFFECT

Jan 27, 2026

9999999995-26-000309

—

1.7 KB

POS AM

Jan 26, 2026

0001213900-26-007469POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3

—

21.7 KB

DEF 14A

Dec 29, 2025

0001213900-25-126111DEFINITIVE PROXY STATEMENT

Jan 28, 2026

2.6 MB

PRE 14A

Dec 19, 2025

0001213900-25-123883PRELIMINARY PROXY STATEMENT

Jan 28, 2026

2.6 MB

8-K

Dec 15, 2025

0001213900-25-121466CURRENT REPORT

Dec 12, 2025

233.1 KB

SCHEDULE 13G

Dec 8, 2025

0001274173-25-000343

—

9.6 KB

SCHEDULE 13G

Dec 5, 2025

0002050709-25-000011

—

78.9 KB

SCHEDULE 13G

Dec 5, 2025

0001213900-25-118701

—

22.7 KB

8-K

Dec 2, 2025

0001213900-25-116985CURRENT REPORT

Nov 28, 2025

284.6 KB

Dec 1, 2025

0001213900-25-116309

Nov 28, 2025

4.5 KB

Dec 1, 2025

0001213900-25-116306

Nov 28, 2025

4.4 KB

Dec 1, 2025

0001213900-25-116301

Nov 28, 2025

4.4 KB

Dec 1, 2025

0001213900-25-116299

Nov 28, 2025

4.4 KB

Dec 1, 2025

0001213900-25-116296

Nov 28, 2025

4.4 KB

424B4

Dec 1, 2025

0001213900-25-116286PROSPECTUS

—

227.5 KB

EFFECT

Nov 28, 2025

9999999995-25-003424

—

1.7 KB

S-1/A

Nov 26, 2025

0001213900-25-115595AMENDMENT NO. 1 TO FORM S-1

—

865.4 KB

25 filings shown

Pasithea Therapeutics Corp.

Financials

News (8-K)

Prospectuses & Registrations

Filing History(303 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
12/29/25	DEF 14A	DEFINITIVE PROXY STATEMENT	→
12/19/25	PRE 14A	PRELIMINARY PROXY STATEMENT	→
7/24/25	DEF 14A	DEFINITIVE PROXY STATEMENT	→
7/14/25	PRE 14A	PRELIMINARY PROXY STATEMENT	→
5/28/24	DEF 14A	DEF 14A	→
12/28/23	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
↓

Filed	Form	Description
2/27/26	SCHEDULE 13G	SCHEDULE 13G	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G	SCHEDULE 13G	→
2/12/26	SCHEDULE 13G	SCHEDULE 13G	→
1/27/26	EFFECT	EFFECT	→
↓